Generic filters
Search in excerpt

An ETF for every investor.

HBNK

Horizons Equal Weight Banks Index ETF

Price
$20.96
$0.10
0.48%
NAV
$20.9449
$0.0880
0.42%

Benchmark

Sector Equity

Fact Sheet
Learn more about HBNK

SPAY

Horizons Short-Term U.S. Treasury Premium Yield ETF

Price
$27.04
$0.10
0.37%
NAV
$27.0305
$0.0888
0.33%

Active

Fixed Income

Fact Sheet
Learn more about SPAY

CASH

Horizons High Interest Savings ETF

Price
$50.16
$0.02
0.04%
NAV
$50.1421
$0.0066
0.01%

Benchmark

Fixed Income

Fact Sheet
Learn more about CASH
Explore All Products
Generic filters
Search in excerpt
Back to All Products

PSYK

Horizons Psychedelic Stock Index ETF

Investment Objective

PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index, net of expenses.

Fund Details

Ticker
PSYK
Inception Date
January 26, 2021
Net Assets ?
$10,514,327
As at  February 23, 2024
Consolidated Prior Day Volume ?
4 564
For  February 23, 2024
Average Daily Trading Volume Over a 12 Month Period ?
3,743
As at  February 23, 2024
Exchange
NEO Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
HPSYKTR
Management Fee
0.85%
(Plus applicable sales tax)
Management Expense Ratio ?
1.16%
As at June 30, 2023
Currency
CAD
Currency Hedging
N/A
LEI ?
5493003DII1O2LYBVQ81
Most Recent Distributions Per Unit
$0.03023
12-Month Trailing Yield ?
-- %
Distribution Frequency
Record Date
September 29, 2021
NAV / Unit
$6.4865
Price
$6.45
Premium Discount
$-0.04
Premium Discount Percentage
-0.57%
Outstanding Shares
1,620,954

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Psychedelic Stock Index ETF 14.02 6.49 -18.66 14.02 -17.81 -44.56 -- -- -46.06
North American Psychedelics Index 14.06 7.59 -16.88 14.06 -12.07 -42.82 -- -- -44.33

**Fund performance since inception on January 26, 2021, as at January 31, 2024

Calendar Year Performance (%) *

2016 2017 2018 2019 2020 2021 2022 2023

Horizons Psychedelic Stock Index ETF

-- -- -- -- -- -- -63.48 -20.39
North American Psychedelics Index -- -- -- -- -- -- -62.93 -12.87

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2021 09/28/2021 09/29/2021 10/13/2021 0.03023

Top 10 Holdings

As at February 16, 2024
Security Name Weight
Relmada Therapeutics Inc 16.76%
COMPASS PATHWAYS PLC ADR 13.05%
ATAI LIFE SCIENCES NV . 12.64%
MIND MEDICINE MINDMED INC 10.51%
GH RESEARCH PLC . 9.44%
Numinus Wellness Inc 6.86%
Pharmala Biotech Holdings Inc 6.61%
CYBIN INC . 6.03%
FSD Pharma Inc 5.88%
Abbvie Inc 5.07%

Holdings are subject to change. Download full prior business day: Holdings

At a Glance

Investment Objective

PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index, net of expenses.

Product Facts

Fund Details

Ticker
PSYK
Inception Date
January 26, 2021
Net Assets ?
$10,514,327
As at  February 23, 2024
Consolidated Prior Day Volume ?
4 564
ForFebruary 23, 2024
Average Daily Trading Volume Over a 12 Month Period ?
3,743
As at  February 23, 2024
Exchange
NEO Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
HPSYKTR
Management Fee
0.85%
(Plus applicable sales tax)
Management Expense Ratio ?
1.16%
 As at June 30, 2023
Currency
CAD
Currency Hedging
N/A
LEI ?
5493003DII1O2LYBVQ81
Most Recent Distributions Per Unit
0.03023
Annualized Distribution Yield ?
-- %

As at  February 23, 2024

12-Month Trailing Yield ?
-- %
Distribution Frequency
Record Date
September 29, 2021
NAV / Unit
$6.4865
Price
$6.45
Premium Discount
$-0.04
Premium Discount Percentage
-0.57%
Outstanding Shares
1,620,954

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Performance & Distributions

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Psychedelic Stock Index ETF 14.02 6.49 -18.66 14.02 -17.81 -44.56 -- -- -46.06
North American Psychedelics Index 14.06 7.59 -16.88 14.06 -12.07 -42.82 -- -- -44.33

**Fund performance since inception on January 26, 2021, as at January 31, 2024

Calendar Year Performance (%)

2016 2017 2018 2019 2020 2021 2022 2023
Horizons Psychedelic Stock Index ETF -- -- -- -- -- -- -63.48 -20.39
North American Psychedelics Index -- -- -- -- -- -- -62.93 -12.87

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2021 09/28/2021 09/29/2021 10/13/2021 0.03023
Holdings

Top 10 Holdings

As at February 16, 2024
Security Name Weight
Relmada Therapeutics Inc 16.76%
COMPASS PATHWAYS PLC ADR 13.05%
ATAI LIFE SCIENCES NV . 12.64%
MIND MEDICINE MINDMED INC 10.51%
GH RESEARCH PLC . 9.44%
Numinus Wellness Inc 6.86%
Pharmala Biotech Holdings Inc 6.61%
CYBIN INC . 6.03%
FSD Pharma Inc 5.88%
Abbvie Inc 5.07%

Holdings are subject to change. Download full prior business day: Holdings

Related Posts

At Horizons ETFs, we believe in education as empowerment. We endeavor to equip Canadian investors with the knowledge and tools they need to navigate the investing world. From the ETF basics to more complex topics like how our suite of inverse and leveraged funds work, our comprehensive learning library aims to be accessible for all investors, from beginners to experienced traders!